Sep/Oct 2019 - Volume 23, Number 5

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Sep/Oct 2019 - Volume 23, Number 5

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2019 Pg. 356	PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
Sep/Oct 2019 Pg. 366-375	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Author(s): Zur Eyal
Sep/Oct 2019 Pg. 376-381	Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Author(s): Zur Eyal
Sep/Oct 2019 Pg. 383-385	Threading the Needle Author(s): Brunner Scott
Sep/Oct 2019 Pg. 387-391	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019 Pg. 393-396	Basics: Excipients Used in Nonsterile Compounding, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 399-402	Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 404	Calculations Author(s): Stockton Shelly J
Sep/Oct 2019 Pg. 406	Allopurinol 20 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 407	Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 408	Dipyridamole 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 409	Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 410	Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 412	Valsartan 4 mg/mL in Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 413	Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 414-417	Stability of Furosemide 5 mg/mL in Polypropylene Syringes Author(s): van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
Sep/Oct 2019 Pg. 418-421	Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Author(s): Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Sep/Oct 2019 Pg. 422-427	The Current Landscape of Veterinary Compounding in the Pharmacy Setting Author(s): Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Sep/Oct 2019 Pg. 428-433	The Current Landscape of Veterinary Compounding in the Veterinary Setting Author(s): Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Sep/Oct 2019 Pg. 434-437	Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics Author(s): Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Sep/Oct 2019 Pg. 438	Erratum: McNulty JP, Hahn K. Compounded oral ketamine for severe depression, anxiety, and pain in a hospice patient with end-stage chronic obstructive pulmonary disease, cardiopulmonary failure, and severe : A case report. IJPC. 2012; 16(5): 364–368. Author(s):
Sep/Oct 2019 Pg. 438	Erratum: Stevens JT. Summary of educational offerings provided by compounding support companies in 2019. IJPC. 2019; 23(3): 188–191. Author(s):